Example: Heart Attack

Search clinical trials for: Nandrolone phenpropionate

Total 23 results

NCT02055456

Unknown status

Nandrolone Decanoate in the Treatment of Telomeropathies

Conditions: Aplastic Anemia; Bone Marrow Failure Syndromes; Idiopathic Pulmonary Fibrosis; Telomere Shortening
NCT02376309

Completed

The Effect of Nandrolone Decanoate and Leucine on Muscle Loss

Conditions: Muscle Atrophy
NCT02754687

Active, not recruiting

Single Dose, Dose-Ranging Study of 11-β Methyl Nortestosterone Dodecylcarbonate (11β-MNTDC) in Healthy Men

Conditions: Healthy Men; Male Contraception
NCT03263520

Completed

Impact of the Use of Nandrolone on the Treatment of Malnutrition Induced by Cancer

Conditions: Cachexia; Cancer
NCT00000854

Completed

A Study to Evaluate the Effect of Nandrolone Decanoate in Women With HIV-Associated Weight Loss

Conditions: HIV Infections; HIV Wasting Syndrome
NCT03298373

Active, not recruiting

28-Day Repeat-Dose, Dose Escalation Study of 11-β Methyl Nortestosterone Dodecylcarbonate (11β-MNTDC) in Healthy Men

Conditions: Healthy Men; Male Contraception
NCT03545347

Active, not recruiting

Physiotherapy, Nutritional Supplement and Anabolic Steroids in Rehabilitation of Patients With Hip Fracture.

Conditions: Hip Fractures
NCT00242463

Terminated

Anabolic Steroids for Nutritional Rehabilitation of Critically Ill Patients

Conditions: Malnutrition; Critical Illness
NCT00250536

Completed

Anabolic Steroids and Exercise in Hemodialysis Patients

Conditions: End-Stage Renal Disease; Muscle Weakness
NCT00000597

Completed

Multi-Center Trial of Anti-Thymocyte Globulin in Treatment of Aplastic Anemia and Other Hematologic Disorders

Conditions: Anemia, Aplastic; Hematologic Diseases; Pancytopenia; Blood Disease
NCT00682123

Completed

Risk of Positive Doping Tests Following Ingestion of Supplements Contaminated With Trace Quantities of Nandrolone Metabolites

Conditions: Positive Doping Tests in Sports
NCT00812630

Completed

A Two-part Trial Assessing the Effects of 7α-methyl-19-nortestosterone (MENT) on Blood Pressure in Normal Men: an Open-label Pilot Study Followed by a Randomized, Double-blind, Placebo-controlled Study

Conditions: Blood Pressure
NCT04230083

Completed

Bioavailability of Dienogest 2.0 mg With Regards to Reference Product

Conditions: Bioequivalence
NCT00754871

Completed

Pharmacodynamic Characterization of Dienogest

Conditions: Pharmacodynamics
NCT00302666

Completed

Bleeding Pattern Study

Conditions: Oral Contraceptive
NCT00675714

Terminated

Assessment of the Treatment of Severely Burned With Anabolic Agents on Clinical Outcomes, Recovery and Rehabilitation

Conditions: Burns
NCT00673309

Completed

Assessment of Mechanisms of Improved Wound Healing

Conditions: Burns
NCT03142035

Unknown status

Dienogest Versus GnRH-a Pre-treatment in Women With Endometriosis Undergoing IVF

Conditions: Endometriosis
NCT00941057

Completed

Bioequivalence Study: 2 mg Estradiol Valerate (EV) and 3 mg Dienogest (DNG) Without and With Levomefolate Calcium

Conditions: Pharmacology, Clinical
NCT03789123

Unknown status

Effects of Dienogest and Dienogest Plus Estradiol Valerate in Ovarian Endometrioma

Conditions: Ovarian Reserve
NCT04193852

Completed

Bioavailability of Dienogest and Ethinyl Estradiol Tablets 2.0 mg/0.03 mg With Regards to Reference Product

Conditions: Bioequivalence
NCT02352090

Completed

Synthetic vs Natural Estrogen in Combined Oral Contraception

Conditions: Contraception
NCT01600274

Completed

Bioavailability Study With Oral Single Dose Administration of Ethinylestradiol and Dienogest

Conditions: Focus: Bioequivalence